Item 5.07 - Submission of Matters to a Vote of Security Holders.

Abbott held its Annual Meeting of Shareholders on April 28, 2023. The following is a summary of the matters voted on at that meeting.

(1) The shareholders elected Abbott's entire Board of Directors. The persons

elected to Abbott's Board of Directors and the number of shares cast for, the

number against, the number abstaining, and the number of broker non-votes,


     with respect to each of these persons, were as follows:




Name                                   Votes For        Votes Against        Abstain        Broker Non-Votes

Robert J. Alpern, M.D.                1,300,233,845         40,999,800       2,550,022            179,678,846
Claire Babineaux-Fontenot             1,332,221,117          9,143,433       2,419,117            179,678,846
Sally E. Blount, Ph.D.                1,313,562,636         27,670,360     

 2,550,671            179,678,846
Robert B. Ford                        1,237,921,513         98,282,136       7,580,018            179,678,846
Paola Gonzalez                        1,328,031,021         13,237,327       2,515,319            179,678,846
Michelle A. Kumbier                   1,317,451,283         23,688,351       2,644,033            179,678,846
Darren W. McDew                       1,325,003,048         16,239,864       2,540,755            179,678,846
Nancy McKinstry                       1,011,927,390        329,238,357       2,617,920            179,678,846
Michael G. O'Grady                    1,334,239,902          7,000,568       2,543,197            179,678,846
Michael F. Roman                      1,315,610,421        252,575,883       2,597,363            179,678,846
Daniel J. Starks                      1,301,202,274         40,033,804       2,547,589            179,678,846
John G. Stratton                        967,449,428        373,674,636       2,659,603            179,678,846

(2) The shareholders ratified the appointment of Ernst & Young LLP as Abbott's

auditors. The number of shares cast in favor of the ratification of Ernst &

Young LLP, the number against, the number abstaining, and the number of
     broker non-votes were as follows:




      For             Against          Abstain       Broker Non-Votes
  1,505,489,277       13,849,792       4,123,444                 0

(3) The shareholders approved the compensation of Abbott's named executive

officers listed in the proxy statement for the Annual Meeting, with 90.01

percent of the votes cast voting "For" the proposal. The shareholder vote is

advisory and non-binding. The number of shares cast in favor of approval, the

number against, the number abstaining, and the number of broker non-votes


     were as follows:




      For              Against          Abstain        Broker Non-Votes
  1,209,481,630       126,986,023       7,316,014          179,678,846

(4) The shareholders voted to approve Abbott's Board of Directors' recommendation

that Abbott present shareholders with the opportunity to vote on the

compensation awarded to its named executive officers annually, with 97.86

percent of the votes cast voting "1 Year" for the proposal. The shareholder

vote is advisory and non-binding. The number of shares cast in favor of

holding the vote annually, every two years or every three years, the number


     abstaining, and the number of broker non-votes were as follows::




     Annual           Every Two Years       Every Three Years

Abstain Broker Non-Votes


  1,315,122,068           2,786,024              20,535,518            5,340,057            179,678,846

(5) The shareholders rejected a shareholder proposal to lower the ownership

threshold for calling special meetings of shareholders, with 4.26 percent of

the votes cast voting "For" the proposal. The number of shares cast in favor

of the shareholder proposal, the number against, the number abstaining, and


     the number of broker non-votes were as follows:




    For              Against           Abstain         Broker Non-Votes
  57,301,192       1,263,777,321       22,705,154          179,678,846

(6) The shareholders rejected a shareholder proposal requesting that Abbott's

Board of Directors adopt a policy that the Board Chairman be an independent

director, with 30.46 percent of the votes cast voting "For" the proposal. The

number of shares cast in favor of the shareholder proposal, the number


     against, the number abstaining, and the number of broker non-votes were as
     follows:




     For             Against          Abstain        Broker Non-Votes
  409,310,217       929,751,192       4,722,258          179,678,846

(7) The shareholders rejected a shareholder proposal that Abbott's Board of

Directors prepare a report, to be updated annually, disclosing Abbott's

lobbying policies, procedures, and expenditures, with 22.97 percent of the

votes cast voting "For" the proposal. The number of shares cast in favor of

the shareholder proposal, the number against, the number abstaining, and the

number of broker non-votes were as follows:






     For              Against           Abstain         Broker Non-Votes
  308,723,008       1,021,514,862       13,545,797          179,678,846

(8) The shareholders rejected a shareholder proposal that Abbott's Board of

Directors adopt a policy that no financial performance metric shall be

adjusted to exclude legal or compliance costs when evaluating performance for

the purpose of senior executive compensation, with 14.44 percent of the votes

cast voting "For" the proposal. The number of shares cast in favor of the

shareholder proposal, the number against, the number abstaining, and the


     number of broker non-votes were as follows:




     For              Against           Abstain        Broker Non-Votes
  194,062,534       1,143,000,240       6,720,893          179,678,846

© Edgar Online, source Glimpses